ライフサイエンスコーパス: Thailand

1 northern, northeastern or central regions of Thailand).

2 the Congo, India, Philippines, South Africa, Thailand).

3 atosis (Pakistan, Bangladesh, Sri Lanka, and Thailand).

4 perties of stingless bee honey from SE Asia (Thailand).

5 egetables and fruits collected from Southern Thailand.

6 V-negative persons conducted in Botswana and Thailand.

7 hern Africa and men who have sex with men in Thailand.

8 ns of China and South Korea, and possibly in Thailand.

9 America, and as low as 7-9% in Mongolia and Thailand.

10 live-attenuated influenza vaccine (LAIV) in Thailand.

11 he village boundary into a natural forest in Thailand.

12 seudomallei, a common cause of septicemia in Thailand.

13 parameterized using country-level data from Thailand.

14 al centers in the United States, Europe, and Thailand.

15 ginger plant in the tropical dry forests of Thailand.

16 consequence of the demographic transition in Thailand.

17 135) and P falciparum (n = 77) isolates from Thailand.

18 49% and ranged from 27% in Brazil to 78% in Thailand.

19 ross seven sites in Brazil, Peru, India, and Thailand.

20 s were seen in Malaysia, the Philippines, or Thailand.

21 enic mice and in seropositive individuals in Thailand.

22 inic at Chiang Mai University in Chiang Mai, Thailand.

23 nvironmental risk factors for oral clefts in Thailand.

24 s infection from Malaysia, South Africa, and Thailand.

25 rEP among men who have sex with men (MSM) in Thailand.

26 c surveillance site of 100 villages in rural Thailand.

27 le role in shaping pertussis epidemiology in Thailand.

28 conservation areas in Kanchanaburi province, Thailand.

29 tched females without diabetes in Khon Kaen, Thailand.

30 ltisite hospital-based case-control study in Thailand.

31 ss Society, Aranyaprathet District, Sa Kaeo, Thailand.

32 university-based medical center in northern Thailand.

33 recent success of the RV144 vaccine trial in Thailand.

34 italized with acute respiratory infection in Thailand.

35 ines, Russia, South Africa, South Korea, and Thailand.

36 nd vegetables during a 2 week field study in Thailand.

37 rging artemisinin resistance in northwestern Thailand.

38 tive control subjects (n = 10) from Bangkok, Thailand.

39 ng, Nakhon Ratchasima Province, northeastern Thailand.

40 raphic cluster study was undertaken in rural Thailand.

41 aj Nakorn Chiang Mai Hospital in Chiang Mai, Thailand.

42 ates, Europe, Australia, Canada, Israel, and Thailand.

43 in a cohort of dengue-infected children from Thailand.

44 , and from endemic and nonendemic regions of Thailand.

45 ing with acute diarrhea during deployment in Thailand.

46 s collected from children in Kamphaeng Phet, Thailand.

47 ar-old female who had recently traveled from Thailand.

48 from a patient with inflammatory diarrhea in Thailand.

49 den of dengue-related illness in children in Thailand.

50 ospitalized patients with pneumonia in rural Thailand.

51 the epidemiology of HCoV infection in rural Thailand.

52 and 31 August 2005 in the same hospitals in Thailand.

53 miae) were isolated from human patients from Thailand.

54 treatment of MERS-CoV infections imported to Thailand.

55 ive hospital clinics in Uganda, the USA, and Thailand.

56 ant TB are major challenges of TB control in Thailand.

57 om HIV-uninfected participants from Bangkok, Thailand.

58 odia and 15 of 15 isolates from northeastern Thailand.

59 are for treatment of HCV genotype 1 and 6 in Thailand.

60 Z) in imported Pangasius catfish products in Thailand.

61 ai language-grown in four major provinces in Thailand.

62 ted in Puerto Rico, Colombia, Singapore, and Thailand.

63 a vaccine in this HIV-infected population in Thailand.

64 sent from 8859 children in 364 hospitals in Thailand.

65 an environmental bacillus found in northeast Thailand.

66 ve survival of colorectal cancer patients in Thailand.

67 ment and private hospitals from all parts of Thailand.

68 enza vaccine in HIV-infected men in Bangkok, Thailand.

69 hildren with HIV after 7 years of rollout in Thailand.

70 nly chronic hepatitis C genotypes 2 and 3 in Thailand.

71 kok, and the Shoklo Malaria Research Unit in Thailand.

72 ected from 3 gardens in Nonthaburi province, Thailand.

73 account for 30-50 % of all HCV infection in Thailand.

74 ll subsets in dengue patients from India and Thailand.

75 d the lowest for Indonesia, South Korea, and Thailand (0 to 0.3%).

76 s (Canada [11], Argentina [1], Peru [1], and Thailand [1]).

77 ts were coinfected with recent avian H5N1 (A/Thailand/16/04) and human H3N2 (A/Wyoming/3/03) viruses.

78 Furthermore, A/Thailand/16/2004 and A/Vietnam/1203/2004 (VN/1203) H5N1

79 lower than a virulent Asian-lineage H5N1 (A/Thailand/16/2004) virus.

80 ections in schoolchildren in Kamphaeng Phet, Thailand (1998-2002 and 2004-2007).

81 ppines (1), Sierra Leone (11), Tanzania (5), Thailand (2), Uganda (9), and Zimbabwe (15).

82 The RV144 HIV-1 vaccine trial (Thailand, 2003 to 2009), using immunogens genetically ma

83 om 2008 to 2010), and Wang Pha, northwestern Thailand (2009-2010), patients with uncomplicated falcip

84 search Council used the Bangkok Declaration, Thailand, 2009, as a guideline for their food compositio

85 5 635 travellers; 70 million residents), and Thailand (29 241 travellers; 59 million residents).

86 ized pneumonia patients in Sa Kaeo Province, Thailand, 53 (4.5%) were reproducibly positive for HBoV

87 17,291 cases) data, we show that in Bangkok, Thailand, 60% of dengue cases living <200 meters apart c

88 ected in 65 of 88 isolates from northeastern Thailand, 86 of 111 isolates from southern Laos, and 14

89 ], Brazil [8.7- 9.7], Chile [8.84-10.0], and Thailand [9.1-10.0]; there was perfect agreement between

90 ntify mortality due to seasonal influenza in Thailand, a tropical middle-income country.

91 eillance) and in 127 asymptomatic persons in Thailand (active surveillance).

92 women and infants and CRF01(subtype AE) from Thailand; all subjects were NRTI naive.

93 The occurrence of G. cf. bengawanicus in Thailand allows us to propose a scenario for the dispers

94 culture-confirmed melioidosis patients from Thailand along with 188 healthy donors from Thailand and

95 . and Australia) and 1,706 mothers of Asian (Thailand) ancestry from the HAPO cohort.

96 randomized controlled trial in northwestern Thailand and 2 trials in Papua, Indonesia, to identify a

97 f 492 patients with P. vivax infections from Thailand and 476 patients (162 with concurrent falciparu

98 Thailand along with 188 healthy donors from Thailand and 90 healthy donors from the United States as

99 n Myanmar, and in relevant border regions in Thailand and Bangladesh, between January, 2013, and Sept

100 s of dengue burden corresponding to those in Thailand and Brazil, respectively, to determine vaccine

101 All 46 MDR M. tuberculosis genomes from both Thailand and California were highly related, with a medi

102 cation in 6 patients from clinical trials in Thailand and Cambodia who were classified as being reinf

103 n outbreak of tuberculosis among refugees in Thailand and consecutive cases within California.

104 In Thailand and Cote d'Ivoire, focusing treatment only on F

105 t in Australia, and group YLF is dominant in Thailand and elsewhere.

106 ratory infection in hospitalized patients in Thailand and evaluated clinical characteristics associat

107 ed area systems on poverty in Costa Rica and Thailand and find that although communities near protect

108 fetal hemoglobin levels (P = 2.6E-21) and in Thailand and Hong Kong subjects.

109 hemoglobin E or beta thalassemia trait from Thailand and Hong Kong.

110 of intrahepatic cholangiocarcinoma (ICC) in Thailand and identify the prognostic factors for all-cau

111 der between eastern Myanmar and northwestern Thailand and in western Cambodia.

112 arose in western Cambodia and then spread to Thailand and Laos, outcompeting other parasites and acqu

113 ed from HIV-exposed children in hospitals in Thailand and mailed to the Faculty of Associated Medical

114 Particularly in Thailand and most neighbouring low-income countries, scr

115 Although the disease is more prevalent in Thailand and northern Australia, sporadic cases may be e

116 ria pseudomallei, is endemic in northeastern Thailand and Northern Australia.

117 Most cases are reported from northeast Thailand and northern Australia.

118 Emergence of this phenotype in western Thailand and possibly elsewhere threatens to compromise

119 ll subsets in dengue patients from India and Thailand and show that these cells expand massively and

120 ncluding melioidosis patients from Northeast Thailand and Singapore, patients with different infectio

121 i: the original reference strain K96243 from Thailand and strain MSHR305 from Australia.

122 ients and 21 control subjects from Northeast Thailand and studied immune parameters in the context of

123 We enrolled 203 persons from sites in Thailand and Taiwan in five groups: 52 patients with dis

124 (such as central, eastern, and northeastern Thailand and the Ayeyarwady Delta), where narrowing yiel

125 e countries (Indonesia, Malaysia, Singapore, Thailand and Vietnam) had guidelines for influenza vacci

126 producing countries (China, India, Malaysia, Thailand and Vietnam) were newly established to discrimi

127 Of 1,060 patients enrolled in Thailand and Vietnam, where liquid culture was performed

128 donesia (Jakarta and Bali), Lao PDR, Taiwan, Thailand and Vietnam.

129 Trial Centre at Mahidol University, Bangkok, Thailand and was divided into two parts.

130 riraj Hospital, Mahidol University, Bangkok, Thailand) and profiled.

131 .7% versus SE0 in Egypt, 22.0% versus ST0 in Thailand, and 13.1% versus SC0 in Cote d'Ivoire.

132 00-2010 in the United States, South America, Thailand, and Africa.

133 e Gambia, Kenya, Mali, South Africa, Zambia, Thailand, and Bangladesh), through 32 on-site courses an

134 bo-controlled phase 2b study in Peru, India, Thailand, and Brazil allowed determination of geneticall

135 ng Chulalongkorn Memorial Hospital, Bangkok, Thailand, and from the eye camp at the 6th Station of th

136 sing blood from water buffalo in Vietnam and Thailand, and goats in Zambia.

137 uman and fish ST283 isolates from Singapore, Thailand, and Hong Kong.

138 phisms (SNPs) in 91 parasites from Cambodia, Thailand, and Laos identified 33 genome regions under st

139 to Leishmania enrietti, with cases in Ghana, Thailand, and Martinique; other relatives infect Austral

140 CD4 count, age >35 years, birth in northern Thailand, and positive anti-hepatitis C virus serology.

141 ase 3 trial was done at 36 centres in China, Thailand, and South Korea.

142 ssian Federation, South Africa, South Korea, Thailand, and Taiwan.

143 ed anew at Bangladesh, Ethiopia, Kyrgyzstan, Thailand, and the Indian state of Tamil Nadu, which have

144 s from the Ivory Coast, Kenya, South Africa, Thailand, and the United States, and 1% were identified

145 ion-making in four basins in Brazil, Mexico, Thailand, and the United States.

146 ls from Brazil, Ecuador, Peru, South Africa, Thailand, and the USA were enrolled into an open-label P

147 ites in Brazil, Ecuador, Peru, South Africa, Thailand, and the USA.

148 ix from each location: Ecuador, Philippines, Thailand, and United States) were studied; two were clas

149 ates from Australia than among isolates from Thailand, and vice versa.

150 aso, Cameroon, Cote d'Ivoire, Senegal, Togo, Thailand, and Vietnam to assess virological failure and

151 solates of P. marneffei obtained from China, Thailand, and Vietnam were analyzed by nucleotide sequen

152 Asia (Indonesia, Malaysia, the Philippines, Thailand, and Vietnam) from June 2011 through December 2

153 uding Bangladesh, Cambodia, India, Tanzania, Thailand, and Vietnam, suggest that advances in disease

154 ng 15 post-trafficking services in Cambodia, Thailand, and Vietnam.

155 n from eight outpatient clinics in Cambodia, Thailand, and Vietnam.

156 desh, the Gambia, Kenya, Mali, South Africa, Thailand, and Zambia).

157 desh, The Gambia, Kenya, Mali, South Africa, Thailand, and Zambia.

158 m Brazil, India, Malawi, Peru, South Africa, Thailand, and Zimbabwe were randomized to 3 antiretrovir

159 ru, and one each in Brazil, Kenya, Tanzania, Thailand, and Zimbabwe).

160 valence and mortality attributable to MDR in Thailand are high.

161 n be probably explained by the popularity of Thailand as a vacation destination characterized by sex

162 ani, is more closely related to cytoforms in Thailand, as are populations from Taiwan previously trea

163 osed of isolates obtained only from China or Thailand, as well as clusters with a combination of isol

164 es (San Francisco, CA), Nigeria (Maiduguri), Thailand (Bangkok), and Nepal (Kathmandu) revealed seque

165 Africa in the mid-1970s, was introduced into Thailand between 1979 and 1982, and began expanding ther

166 capillariasis at Siriraj Hospital, Bangkok, Thailand between 2001- 2013.

167 and Treatment observational cohort study in Thailand between 2002 and 2010 were included.

168 ica, Mexico, the Philippines, Singapore, and Thailand between February 2010 and August 2011.

169 s delayed parasite clearance in the Cambodia-Thailand border area raises a serious concern.

170 In the smaller cohort from Thailand, both inflammation and pigment scores were asso

171 We analyzed pertussis incidence in Thailand--both age-stratified and longitudinal aggregate

172 In the upper Gulf of Thailand, Bryde's whales, which feed on small fish speci

173 This regimen is used in Thailand but is associated with side-effects and poor ad

174 are associated with substantial mortality in Thailand, but evidence for the strong relationship betwe

175 with pneumonia among young children in rural Thailand, but infection and illness may be dependent on

176 Cambodia and has recently emerged in western Thailand, but is absent from neighboring Laos.

177 fections were infrequently detected in rural Thailand by use of sensitive real-time RT-PCR assays.

178 or tolerance in Plasmodium falciparum on the Thailand-Cambodia border makes protection of the effecti

179 cratic Republic of Congo to 7.0 hours at the Thailand-Cambodia border.

180 S+MQ)-resistant Plasmodium falciparum in the Thailand-Cambodia region is a major concern for malaria

181 ne to late Miocene sites in Pakistan, India, Thailand, China, and Japan.

182 Thailand, China, and Vietnam had set out a strategic vis

183 lus ribavirin was dominant or cost-saving in Thailand compared to a palliative care.

184 In Thailand, compared with pooled real-time PCR, RealAmp de

185 es (Kenya, Burkina Faso, Mali, Cambodia, and Thailand) detected population genetic differences betwee

186 , Egypt, Guatemala, Kenya, South Africa, and Thailand) during 2004-2012.

187 al precipitation (Bangladesh, Guatemala, and Thailand) during wet months, whereas RSV peaked during c

188 peat infections to pertussis epidemiology in Thailand following a pronounced increase in vaccine upta

189 om 2004 through 2009 in 2 rural provinces in Thailand for the presence of CrAg+.

190 rt of children at primary school in northern Thailand from 1998 to 2002.

191 abases of nine public hospitals in northeast Thailand from 2004 to 2010, and linked these with the na

192 s provided by the National AIDS Programme in Thailand from 2007.

193 ess than 100/muL treated at an HIV clinic in Thailand from June 2010 through June 2012.

194 behavioural risk factors in MSM in Bangkok, Thailand, from 2006 to 2013.

195 ent at a tertiary medical center in northern Thailand had advanced CMV retinitis, possibly because of

196 In 2011, Thailand had the highest combined reported rate of vacci

197 We show that Thailand has been the source of viral dispersal to most

198 rly 2000s in China, Indonesia, Malaysia, and Thailand has continued, and the "newcomers"--India and V

199 The use of stone tools by macaques in Thailand has reduced the size and population density of

200 Thailand has the highest average yearly reduction in mor

201 Studies on Mycoplasma pneumoniae in Thailand have focused on urban centers and have not incl

202 f Japan, Taiwan, the Philippine Islands, and Thailand, identified 106 strains that carry only a singl

203 s within these regions in 715 parasites from Thailand, identifying a selective sweep on chromosome 13

204 al-acquired infection due to MDR bacteria in Thailand in 2010 represented excess mortality caused by

205 sessed the performance of 17 laboratories in Thailand in analysing mandatory nutrients in salted, fri

206 The central role of Thailand in the global spread of CRF01_AE can be probabl

207 with LAIV is likely to be cost-effective in Thailand in the short term, though the long-term consequ

208 contexts, including many western countries, Thailand, India, the Democratic Republic of Congo, Kenya

209 sociated cryptococcal meningitis in Vietnam, Thailand, Indonesia, Laos, Uganda, and Malawi.

210 could be used to divide the 48 isolates from Thailand into 23 VAT types and the 44 isolates from Aust

211 The disease burden of patients with ICC in Thailand is significant with the incidence rate of 14.6

212 lion-year-old Proganochelys from Germany and Thailand, it retains marginal teeth and lacks a carapace

213 was introduced to the Maela refugee camp in Thailand, July 2004.The effect of the length of gestatio

214 bedded placental samples from Karen women in Thailand (low-transmission area) were selected from amon

215 of 49 cART-naive HIV-infected subjects from Thailand (mean baseline CD4 count, 188 cells/microL; mea

216 s, and private physician offices in the USA, Thailand, Mexico, Argentina, and Australia.

217 , Vietnam, and Laos and the other in western Thailand, Myanmar, and China--with no overlap.

218 o address the risk of transmission along the Thailand-Myanmar border and represents a promising tool

219 modalities of malaria transmission along the Thailand-Myanmar border are poorly understood.

220 yment of mefloquine-artesunate (MAS3) on the Thailand-Myanmar border has led to a sustained reduction

221 artemisinin-based combination (MAS3) on the Thailand-Myanmar border.

222 = 6,666 pregnancies, six sites) and one from Thailand (n = 23,952).

223 LRs) were evaluated for VAD in children from Thailand (n = 37) and Zambia (n = 128).

224 ithin Asia (Vietnam, n = 11; Bhutan, n = 12; Thailand, n = 1; Cambodia, n = 1) and two outside of Asi

225 ere conducted in Bangladesh, in northwestern Thailand near the Myanmar border, and at two sites in we

226 areas in Brazil, Costa Rica, Indonesia, and Thailand on carbon storage in forests.

227 the protected area systems in Costa Rica and Thailand, on average, reduced deforestation and alleviat

228 hic analysis indicated that GI-a diverged in Thailand or Cambodia and has remained confined to tropic

229 CI; 1.2-1.4), living in the northern part of Thailand (OR = 1.5, 95% CI; 1.3-1.8) and presence of com

230 ars in posttrafficking services in Cambodia, Thailand, or Vietnam, which along with Laos, Myanmar, an

231 If PrEP were to be implemented in Thailand, our findings show that its uptake could be con

232 o prevent influenza transmission in Bangkok, Thailand, over 34 months between 2008 and 2011, we estim

233 iparum isolates from five sites in Northwest Thailand, over the period of a rapid increase in the eme

234 n acute and recurrent infections (P = .48 in Thailand, P = .08 in Indonesia).

235 outbreak in 2014 in Ubon Ratchatani, Eastern Thailand, parasites from 101 patients with falciparum ma

236 enrolled from 8 sites in the United States, Thailand, Peru, and South Africa with mean age of 31.1 y

237 ence = 14.7%; 45,000 patients treated/year), Thailand (prevalence = 2.2%; 1,000 patients treated/year

238 From a cohort study among schoolchildren in Thailand, PRNT values were determined in serum samples c

239 ive population-based surveillance in 2 rural Thailand provinces during 2008-2011.

240 m infections has been conducted in two rural Thailand provinces for >7 years.

241 related but distinct allelic variants within Thailand, rather than the occurrence of a single outbrea

242 , Egypt, France, Germany, India, Norway, and Thailand) recruited participants who had reliable inform

243 icularis) in Khao Sam Roi Yot National Park, Thailand, reduces prey size and prey abundance, with mor

244 randomized, double-blind, efficacy trial in Thailand reported that a prime-boost human immunodeficie

245 Thailand Research Fund, the Melioidosis Research Center,

246 7 positive cases were detected in India and Thailand, respectively, via PCR.

247 infection in a community-based population in Thailand (RV144 trial).

248 Health care providers in Thailand should evaluate HIV-infected patients hospitali

249 aureus isolates from unselected patients in Thailand showed that 10 (4.1%) were actually Staphylococ

250 t station pair (PSI in Indonesia and CHTO in Thailand) shows significant time shifts (up to 1.44 s) a

251 es in five countries/states: Mexico, Brazil, Thailand, Singapore and Taiwan.

252 t-line virologic failure in individuals from Thailand, South Africa, India, Malawi, Tanzania.

253 lciparum isolates from Myanmar, northeastern Thailand, southern Laos, and western Cambodia for PfKelc

254 A study in Thailand suggests condom machines may provide comfortabl

255 erized isolates from a hospital in northeast Thailand support the view that at least 90% of HA-MRSA i

256 infection were recruited from study sites in Thailand, Tanzania, Uganda, and Kenya with high HIV-1 pr

257 acaque stone tools from Piak Nam Yai Island, Thailand, that had been collected following behavioural

258 In Thailand, the cumulative incidence of gametocytemia betw

259 duals from the United States, Australia, and Thailand, the majority of whom were on HAART at study en

260 igh in countries as diverse as China, Kenya, Thailand, the UK, and the USA, with substantial disparit

261 Within Thailand these chains quickly mix, and by the next dengu

262 tional Institute of Child Health in Bangkok, Thailand, this article provides the authors' perspective

263 ntries, ranging from 3.37% (3.06 to 3.63) in Thailand to 11.00% (9.29 to 12.47) in China.

264 he world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the

265 hase 2, open-label study at three centers in Thailand to assess the antimalarial efficacy, safety, an

266 ia, Malaysia, Pakistan, the Philippines, and Thailand to discuss common challenges to the burden pose

267 We use a variety of different datasets from Thailand to study not only the extremes of micro and mac

268 opia, France, Ghana, Indonesia, Japan, Peru, Thailand, Turkey, and Vietnam), representing diverse geo

269 India, Mexico, Philippines, Poland, Russia, Thailand, Turkey, Ukraine, Uruguay, and Vietnam).

270 V from ten hospital clinics in South Africa, Thailand, Uganda, and the USA.

271 prospectively for 10 weeks during trials in Thailand, Uganda, Malawi, and South Africa.

272 Kong, Israel, Italy, Russia, Spain, Taiwan, Thailand, UK, and USA).

273 , Japan, South Korea, Spain, Sweden, Taiwan, Thailand, UK, and USA.

274 e results were then combined with those from Thailand using aggregated data meta-analysis with a rand

275 Thailand was co-cultured with B. pseudomallei and produc

276 uninfected control subjects) in northwestern Thailand was conducted.

277 Thailand was excluded from incidence analyses because of

278 of the malarial vector Anopheles scanloni in Thailand was studied using mitochondrial DNA sequences.

279 mic data on 88 P. vivax samples from western Thailand, we identified pvmdr1 amplification in 17 isola

280 ng coastal protection values of mangroves in Thailand, we show that the optimal land use option may i

281 ilar data for Malaysia, the Philippines, and Thailand were also extracted but were incomplete.

282 m an additional 135 febrile individuals from Thailand were also used.

283 (CPO) production by a wet extraction mill in Thailand were developed.

284 viverrini eggs, of residents in Northeastern Thailand were investigated for associations among infect

285 han half of diabetic melioidosis patients in Thailand were prescribed glibenclamide.

286 esma bunius) cultivars grown in Northeastern Thailand were quantified using HPLC analysis and the ant

287 n four sites in Africa and 14 communities in Thailand were randomly allocated in matched pairs to rec

288 nant women in Bangalore, India, and Bangkok, Thailand, were randomly assigned (1:1) to receive 200 mu

289 is information comes from Phra Thong Island, Thailand, where a sequence of four stacked sandsheets se

290 oolchildren in the Mueang Rayong district of Thailand, where a similar study had been conducted in 19

291 1_AE originated in Africa and then passed to Thailand, where it established a major epidemic.

292 sier to achieve in regions such as China and Thailand, where the epidemic is more recent and the viru

293 _AE is the predominant circulating strain in Thailand, where the RV144 trial took place.

294 rget children for dengue mass vaccination in Thailand, whereas young adults should be targeted in Bra

295 such as Botswana, Brazil, South Africa, and Thailand, which have already established viral load prog

296 s (HIV)-negative women aged 20-37 years from Thailand who were followed for 18 months at 6-month inte

297 d mononuclear cells (PBMCs) from children in Thailand with acute primary or secondary DENV-1 infectio

298 >/=15 years) from five centres in northeast Thailand with culture-confirmed melioidosis who had rece

299 e is no evidence for pertussis resurgence in Thailand, with each model examined pointing to a substan

300 Despite its multiple challenges, MSM in Thailand would be willing to take PrEP, even if they had